SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-049090
Filing Date
2010-05-13
Accepted
2010-05-13 16:53:15
Documents
4
Period of Report
2010-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c01097e8vk.htm 8-K 20424
2 EXHIBIT 99.1 c01097exv99w1.htm EX-99.1 51107
3 EXHIBIT 99.2 c01097exv99w2.htm EX-99.2 9107
4 GRAPHIC c01097p0109701.jpg GRAPHIC 10474
  Complete submission text file 0000950123-10-049090.txt   97012
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 10829295
SIC: 2834 Pharmaceutical Preparations